BDTX FY 2021 Earnings — Black Diamond Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

BDTXBlack Diamond Therapeutics, Inc.

$125M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$127M

Net Income

-$126M

EPS (Diluted)

$-3.47

Cash Flow

Operating Cash Flow

-$100M

Free Cash Flow

-$103M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$248M

Total Liabilities

$52M

Stockholders' Equity

$196M

Cash & Equivalents

$66M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$127M	-$70M	-82.4%
Net Income	-$126M	-$67M	-86.7%